Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

(L to R) James Cameron and Dr. Samuel Ramsey talk 'Secrets of the Bees'. Premiering March 31st on National Geographic, and ...

One protocol betrays your entire browsing history. Once you fix it, you'll never feel safe without it again.

While evaluating the impact of AI on the labor market is complex, we can distill both optimistic and pessimistic views into ...

And her willingness to square up with the uglier aspects of internet culture made her a target of its ire — which, in turn, ...

For most companies, the honest answer is: nobody knows.

Relying on one giant AI model for everything is a trap; it’s too expensive and slow for simple tasks and too risky for the ...

Asia’s largest contemporary art fair begins with creatives and galleries represented from across Middle East and North Africa ...

Adam Page on the unsung heroes of horror… Obviously, I’m not going sit here and argue that Puppet Master 4 is Citizen Kane. I would insult both movies, and more importantly, I would miss the ...

The market overvalues AGI as LLMs plateau, but BRK.A and UNH leverage AI for gains while others face bubble risks. Find out ...

With its sharp focus on pop-inflected visual languages and regionally rooted sensibilities, this year’s edition rewards serious looking.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...